Related Experiment Video
Updated: May 23, 2026

Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets
Published on: July 16, 2021
Reformulation of Stmerin(®) D CFC formulation using HFA propellants
Saburo Murata1, Takashi Izumi, Hideki Ito
1Pharmaceutical Research and Technology Laboratories, Astellas Pharma Inc. Yaizu, Japan. saburo.murata@astellas.com
This study successfully reformulated Stmerin® D using hydrofluoroalkanes (HFAs) as propellants, improving drug suspension stability with medium-chain triglycerides (MCT) and optimizing spray performance through actuator adjustments for a viable alternative to CFCs.
Area of Science:
- Pharmaceutical Technology
- Inhalation Drug Delivery
- Materials Science
Background:
- Chlorofluorocarbons (CFCs) are being phased out as metered dose inhaler (MDI) propellants.
- Hydrofluoroalkanes (HFAs) are proposed as environmentally friendly alternatives.
- Reformulating existing CFC-based inhalers to HFAs presents formulation and performance challenges.
Purpose of the Study:
- To evaluate the suspension stability and spray performance of a reformulated Stmerin® D using HFAs (HFA-134a and HFA-227) compared to the original CFC formulation.
- To identify suitable surfactants and co-solvents for improving drug suspension in HFAs.
- To optimize actuator configurations for achieving comparable spray performance to the original CFC-based MDI.
Main Methods:
- Preparation of metered dose inhalers (MDIs) using HFA propellants with various surfactants and co-solvents.
- Visual testing to assess drug suspension stability in different HFA formulations.
- Cascade impaction studies to evaluate spray performance, including fine particle dose (FPD).
- Modification of actuator orifice diameter and cone angle to control spray characteristics.
Main Results:
- Drug suspension stability was initially poor in both HFA-134a and HFA-227 formulations.
- Addition of medium-chain triglycerides (MCT) significantly improved suspension stability, especially with HFA-227.
- The higher vapor pressure of HFA-227 led to an increased fine particle dose (FPD).
- Spray performance was successfully controlled by altering actuator configuration, with a 0.8 mm orifice and 90° cone angle yielding results comparable to the original CFC formulation.
Conclusions:
- Reformulation of Stmerin® D using HFA-227 is feasible.
- Medium-chain triglycerides (MCT) are effective suspending agents for HFA-based inhaler formulations.
- Actuator design is a critical factor in achieving desired spray performance for HFA MDIs, enabling a successful transition from CFCs.
Related Concept Videos
Supercritical Fluid Chromatography
SFC utilizes a supercritical fluid mobile phase,...
Chair Conformation of Cyclohexane
The hydrogen atoms linked to carbons are arranged in two different axial and equatorial orientations to achieve this staggered...
Standard Enthalpy of Formation
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

